血浆尿酸水平遗传风险评分与2型糖尿病早期肾功能快速下降相关
在1300例正常白蛋白尿的2型糖尿病患者中,血浆尿酸每升高1个标准差与慢性肾病发病风险升高相关(DN队列校正HR=1.40,SMART2D队列校正HR=1.31)。基于10个东亚人群尿酸相关单核苷酸多态性的加权遗传风险评分与肾功能快速下降的比值比升高相关(荟萃校正OR=1.12),孟德尔随机化分析提示血浆尿酸可能对早期eGFR下降具有因果作用。
要点
- 血浆尿酸每升高1个标准差,DN队列新发CKD风险校正HR=1.40(95%CI 1.02-1.91),SMART2D队列校正HR=1.31(95%CI 1.04-1.64)。
- 加权遗传风险评分升高与新发肾功能快速下降的OR=1.12(95%CI 1.01-1.24,P=0.030)相关。
- 孟德尔随机化分析提示血浆尿酸可能对2型糖尿病患者的早期eGFR下降具有因果作用。
核心结论
- 血浆尿酸升高是新发慢性肾病的独立危险因素。
- 血浆尿酸可能对2型糖尿病患者的早期eGFR下降具有因果作用。
研究设计与样本
- 在2个2型糖尿病研究队列(DN,n=402;SMART2D,n=898)的1300例正常白蛋白尿患者中,采用多变量Cox回归评估血浆尿酸与新发慢性肾病之间的风险比(HR)。
- 基于东亚人群尿酸全基因组关联研究识别的10个单核苷酸多态性计算加权遗传风险评分(wGRS)。
- 在1146例基线无慢性肾病(eGFR>60 mL/min/1.73m²)的中国2型糖尿病患者(DN,478例;SMART2D,668例)中进行孟德尔随机化分析,以wGRS和单个单核苷酸多态性作为遗传工具变量,肾功能快速下降定义为eGFR每年下降≥5 mL/min/1.73m²。
主要发现
- SMART2D和DN队列平均随访分别为5.2年和5.4年,分别有81例(9%)和46例(11%)参与者发生慢性肾病。
- 血浆尿酸每升高1个标准差,新发慢性肾病风险升高:DN队列校正HR=1.40(95%CI 1.02-1.91,P=0.036),SMART2D队列校正HR=1.31(95%CI 1.04-1.64,P=0.018)。
- 加权遗传风险评分升高与肾功能快速下降的比值比升高相关:荟萃校正OR=1.12(95%CI 1.01-1.24,P=0.030,Phet=0.606)。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
CONTEXT: Observational studies have shown that elevated uric acid (UA) is associated with chronic kidney disease (CKD). However, whether the relationship is causal remains unclear. OBJECTIVE: To determine the association of plasma UA and incident CKD and the causal relationship between plasma UA and rapid decline in kidney function (RDKF) in patients with type 2 diabetes (T2D). METHODS: Multivariable Cox regression was conducted to evaluate the hazard ratio (HR) between plasma UA and incident CKD among 1300 normoalbuminuric patients in 2 T2D study cohorts (DN, n = 402; SMART2D, n = 898). A weighted genetic risk score (wGRS) was calculated based on 10 single nucleotide polymorphism (SNPs) identified in genome-wide association studies of UA in East Asians. Mendelian randomization (MR) analysis was performed among 1146 Chinese T2D patients without CKD (estimated glomerular filtration rate [eGFR] > 60 mL/min/1.73m2) at baseline (DN, 478; SMART2D, 668). The wGRS and individual SNPs were used as genetic instruments and RDKF was defined as eGFR decline of 5 mL/min/1.73m2/year or greater. RESULTS: During mean follow-up of 5.2 and 5.4 years, 81 (9%) and 46 (11%) participants in SMART2D and DN developed CKD, respectively. A 1-SD increment in plasma UA conferred higher risk of incident CKD (DN, adjusted-HR = 1.40 [95% CI, 1.02-1.91], P = 0.036; SMART2D, adjusted-HR = 1.31 [95% CI, 1.04-1.64], P = 0.018). Higher wGRS was associated with increased odds for RDKF (meta-adjusted odds ratio = 1.12 [95% CI, 1.01-1.24], P = 0.030, Phet = 0.606). CONCLUSION: Elevated plasma UA is an independent risk factor for incident CKD. Furthermore, plasma UA potentially has a causal role in early eGFR loss in T2D patients.
引用
- Gurung RL, Yiamunaa M, Liu JJ, et al. Genetic Risk Score for Plasma Uric Acid Levels Is Associated With Early Rapid Kidney Function Decline in Type 2 Diabetes. J Clin Endocrinol Metab. 2022. PMID: 35363857. doi:10.1210/clinem/dgac192
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。